Mid-market private equity firm Palamon Capital Partners (Palamon) has invested in the German medical services business OberScharrer Group. Details of the transaction have not been disclosed.
Headquartered in Fürth, Germany, the OberScharrer Group was founded in 1982 by Dr ManuelOber and Dr Armin Scharrer, and operates seventeen sites across Bavaria and Baden-Wuerttemberg. The Group offers a broad spectrum of specialised ophthalmic treatments providing high quality medical care to public and private patients.
OberScharrer has sought a partnership with Palamon to ensure its ability to finance its continued growth, whilst maintaining its independent status. The founders, who will remain with the business, will continue to lead the Group’s development in-line with its strategy to date. Palamon has made the investment in view of strong demand for outpatient services in Germany due to an ageing population and the ability of specialised outpatient centres to provide treatments more effectively and cost efficiently than hospitals.
Dr Holger Kleingarn (pictured),Partner at Palamon, says: “We are delighted to support OberScharrer with its leading reputation for delivering the highest levels of clinical excellence to its patients. Under the continued leadership of the two founders and Managing Directors, Dr Ober and Dr Scharrer, the Group plans to further build out the existing locations and grow organically in the local region.”
Dr Armin Scharrer, Co-Founder and Managing Director of the OberScharrer Group says: “It was very important for us to have found the right partner for the next stage in the development of OberScharrer whilst retaining our independent status.” Dr Manuel Ober, Co-Founder and Managing Director of the Group, explained: “With Palamon, we have a partner that shares our vision for regional growth and dedication for the excellent patient service we provide.”
This transaction marks Palamon’s fifteenth investment from the Firm’s second fund, Palamon European Equity, II. Palamon’s investment strategy focuses on supporting entrepreneurs and founders across Europe to build their businesses through strategic support and enabling them to access equity financing.
